Leyi Gu
Impact in
- Nephrology top 1%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
- Nephrology 21
- Dialysis and Renal Disease Management 7
- Renal Diseases and Glomerulopathies 6
- Chronic Kidney Disease and Diabetes 5
- Acute Kidney Injury Research 5
-
- Renal and related cancers 4
- Co-authors
- Zhaohui Ni (23 shared papers)Shan Mou (17 shared papers)Xinghua Shao (8 shared papers)Ling Wang (1 shared paper)Jianping Liu (1 shared paper)Ben He (1 shared paper)Qisheng Lin (4 shared papers)Minfang Zhang (6 shared papers)
- Journals
- Cell Death and Disease (4 papers)Renal Failure (3 papers)Blood Purification (3 papers)Nephrology Dialysis Transplantation (3 papers)BMJ Open (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Leyi Gu
41 papers receiving 1.3k citations
Leyi Gu's Hit Papers
Peers
Comparison fields: 5 of 85
- Nephrology 560
- Clinical Biochemistry 149
- Critical Care and Intensive Care Medicine 56
- Endocrinology, Diabetes and Metabolism 96
- Pathology and Forensic Medicine 86
Countries citing papers authored by Leyi Gu
This map shows the geographic impact of Leyi Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyi Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyi Gu more than expected).
Fields of papers citing papers by Leyi Gu
This network shows the impact of papers produced by Leyi Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyi Gu. The network helps show where Leyi Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Leyi Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 213 | |
| 2 | Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis Hit paper breakdown → | 2023 | 153 |
| 3 | 2018 | 114 | |
| 4 | 2005 | 103 | |
| 5 | 2004 | 87 | |
| 6 | 2005 | 73 | |
| 7 | 2014 | 68 | |
| 8 | 2023 | 66 | |
| 9 | 2011 | 55 | |
| 10 | 2018 | 52 | |
| 11 | 2019 | 34 | |
| 12 | 2014 | 31 | |
| 13 | 2023 | 26 | |
| 14 | 2017 | 21 | |
| 15 | 2018 | 20 | |
| 16 | 2023 | 16 | |
| 17 | 2024 | 15 | |
| 18 | 2017 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2017 | 13 |
About Leyi Gu
Leyi Gu is a scholar working on Nephrology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Infectious Diseases and Neurology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (7 papers), Renal Diseases and Glomerulopathies (6 papers), Chronic Kidney Disease and Diabetes (5 papers), Acute Kidney Injury Research (5 papers), Renal and related cancers (4 papers), Diabetes Treatment and Management (3 papers), COVID-19 Clinical Research Studies (3 papers) and Climate Change and Health Impacts (2 papers). The work is most often cited by research in Nephrology (560 citations), Clinical Biochemistry (149 citations), Critical Care and Intensive Care Medicine (56 citations), Endocrinology, Diabetes and Metabolism (96 citations) and Pathology and Forensic Medicine (86 citations). Leyi Gu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhaohui Ni, Shan Mou, Xinghua Shao, Ling Wang, Jianping Liu, Ben He, Qisheng Lin, Minfang Zhang, Tomohito Gohda and Satoshi Horikoshi. Their work appears in journals such as Cell Death and Disease, Renal Failure, Blood Purification, Nephrology Dialysis Transplantation and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.